Drug Topics

AUGUST 26, 2022

Medicare users will see prescription drug pricing reform thanks to the Inflation Reduction Act.

469

469

Pharmacy Times

AUGUST 26, 2022

Additionally, approximately 70% who responded to the EnlivenHealth survey say that one-third or more of their revenue comes from individuals eligible for the government health insurance.

Insurance 139

Insurance 139

Drug Topics

AUGUST 26, 2022

Although further studies are needed to confirm the long-term effects, recent studies have shown the infliximab biosimilar to be a safe, effective, and cost reducing treatment for inflammatory bowel diseases.

460

460

Pharmacy Times

AUGUST 26, 2022

Yoona Kim, PharmD, PhD, co-founder and CEO of Arine, discusses some of the key takeaways from the launch of Mark Cuban's pharmacy Mark Cuban Cost Plus Drug Co.

132

132

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

AUGUST 26, 2022

More of these treatments have been approved, but supply chain issues and cost remain obstacles.

247

247

European Pharmaceutical Review

AUGUST 26, 2022

Scientists from the Gladstone Institutes and University of California San Francisco (UCSF) say a new variation of the CRISPR-Cas9 gene editing system enables especially long DNA sequences to be introduced to precise locations in the genomes of cells with remarkably high efficiency without the need for viral vectors. “One of our goals for many years has been to put lengthy DNA instructions into a targeted site in the genome in a way that doesn’t depend on viral vectors,” commented Alex Marson, MD

Immunization 124

Immunization 124

Pharmacy Times

AUGUST 26, 2022

With the help of pharmacists and a team of health care providers, a better quality of life is possible for patients with Parkinson disease.

123

123

pharmaphorum

AUGUST 26, 2022

A clinical trial has found that a digital care programme for people with musculoskeletal pain developed by Sword Health can improve their productivity at work, even if they also have mental health issues. Sword Health’s virtual musculoskeletal programme care programme pairs patients with a physical therapist they can talk with via telehealth, guiding them through exercises to address pain and other symptoms and also provides cognitive behavioural therapy (CBT) modules to help them develop

120

120

Pharmacy Times

AUGUST 26, 2022

Pemigatinib is the first targeted therapy to gain FDA approval for the treatment of adult patients with relapsed or refractory myeloid/lymphoid neoplasms with FGFR1 rearrangement.

FDA 123

FDA 123

pharmaphorum

AUGUST 26, 2022

BioMarin Pharma has its landmark first approval for Roctavian – the first for a haemophilia gene therapy – and will now have to see if that can convert that into a viable business in Europe. The US biotech claimed conditional marketing approval from the European Commission for Roctavian (valoctocogene roxaparvovec) as a treatment for adults with severe haemophilia A, who don’t have a history of developing the antibodies that inhibit the activity of blood-clotting protein Factor VIII.

FDA 112

FDA 112

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

AUGUST 26, 2022

The FDA has approved glycopyrrolate orally disintegrating tablets (Dartisla ODT; Edenbridge Pharmaceuticals) to reduce symptoms of peptic ulcer as an adjunct to peptic ulcer treatment in adults.

FDA 123

FDA 123

Board Vitals - Pharmacist

AUGUST 26, 2022

The American Board of Psychiatry and Neurology (ABPN) Certification Exam in Child Neurology is a board examination that tests a candidate’s knowledge of the fundamentals of child neurology. The exam is held once a year, and is required to become board certified in Child Neurology. We’ve compiled some of the most frequently asked questions about the test.

Communication 98

Communication 98

Pharmacy Times

AUGUST 26, 2022

As more biosimilars and specialty generics enter the market next year, this could result in a shift in drug spending.

123

123

The Honest Apothecary

AUGUST 26, 2022

I am convinced that one of the reasons why so many healthcare professionals struggle when transitioning to management roles is the sheer messiness of it all. Medical folks are trained to insist upon good order, and rightly so. Chaos is the enemy of workplace safety and patient care. Doctors, nurses, and pharmacists generally prefer consistent and well-defined workflows and have a low tolerance for ambiguity.

Patient Care 98

Patient Care 98

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

AUGUST 26, 2022

Routine depression screening in the primary care setting lowered screening disparities and increased recognition of symptoms for groups at risk of undertreatment, including racial and ethnic minority individuals and patients of older age.

123

123

European Pharmaceutical Review

AUGUST 26, 2022

Moderna has filed patent infringement lawsuits alleging that Pfizer and BioNTech’s COVID-19 vaccine Comirnaty ® infringes patents Moderna filed between 2010 and 2016 covering its foundational messenger RNA (mRNA) technology. The lawsuits were filed in the United States District Court for the District of Massachusetts and the Regional Court of Düsseldorf in Germany.

Vaccines 98

Vaccines Immunization 98

Pharmacy Times

AUGUST 26, 2022

Training and knowledge about appropriate communication with individuals of diverse backgrounds improves adherence, outcomes.

Communication 123

Communication 123

Pharmaceutical Technology

AUGUST 26, 2022

ElevateBio has signed a long-term strategic collaboration with the University of Pittsburgh, US, to establish a biomanufacturing centre for expediting cell and gene therapy development. Under the 30-year deal, ElevateBio will set up its next BaseCamp process development and Good Manufacturing Practice (GMP) manufacturing facility in Pittsburgh. This centre will be equipped with its supporting technologies, such as gene editing induced pluripotent stem cell (iPSC) and cell, vector and protein eng

64

64

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

AUGUST 26, 2022

Risk factors associated with declining health-related quality of life for adult survivors of childhood cancer, such as physical inactivity and chronic health conditions, should be targets of surveillance and intervention.

123

123

pharmaphorum

AUGUST 26, 2022

The rivalry between Moderna and Pfizer/BioNTech in commercialising their COVID-19 vaccines has now spilled over into the courts, in the form of a patent infringement lawsuit. Moderna has filed complaints in the US and Germany claiming that the mRNA technology used to make Pfizer and BioNTech’s Comirnaty vaccine infringes multiple patents that cover its own Spikevax shot.

Vaccines 59

Vaccines Immunization 59

Pharmacy Times

AUGUST 26, 2022

Industry partnerships will be essential to improving access to ketamine, according to expert Kevin Nicholson.

122

122

Pharmaceutical Technology

AUGUST 26, 2022

Novartis has announced plans to completely spin off its generics and biosimilars division, Sandoz, to create a new publicly traded standalone firm. The latest development is intended to increase shareholder value by establishing a top European generics firm and a leader in biosimilars internationally. This will aid shareholders of Novartis to entirely take part in possible upside for Sandoz and Novartis Innovative Medicines businesses in the future.

Generic Medicine 59

Generic Medicine 59

Pharmacy Times

AUGUST 26, 2022

Latanoprost (Xalatan) Sterile Ophthalmic Solution is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

116

116

Pharma Times

AUGUST 26, 2022

The tool uses a series of connected algorithms that can assess if someone has PD from their nocturnal breathing

58

58

Pharmacy Times

AUGUST 26, 2022

A new study suggests that work and private life mental stressors are disrupting sleep in older employees, potentially wreaking havoc on health.

73

73

PharmExec

AUGUST 26, 2022

Capsulomics announces leadership appointment of industry veterans Stacey Gilbert and Lisa Kann.

52

52

Pharmacy Times

AUGUST 26, 2022

Wellblends Immune & Respiratory is a 3-in-1 blend designed with ingredients to provide advanced immune support.

Immunization 65

Immunization 65

PharmExec

AUGUST 26, 2022

The multi-regional agreement aims to commercialize Odevixibat in Canada and Israel, for the treatment of patients with cholestatic liver diseases.

52

52

Pharmacy Times

AUGUST 26, 2022

Canakinumab did not meet the primary endpoint of disease-free survival in adult patients with stages II-IIIA and IIIB completely resected non-small cell lung cancer.

65

65

Pharmaceutical Technology

AUGUST 26, 2022

PathAI has expanded a multi-year partnership agreement with Bristol Myers Squibb (BMS) to leverage artificial intelligence (AI)-powered pathology in translational research and clinical trials. In the initial stage, the deal will focus on key translational research in oncology, fibrosis and immunology areas to advance the work into clinical development.

52

52

Pharmacy Times

AUGUST 26, 2022

Researchers find that the risk of developing dementia increased by 35% in patients with atrial cardiopathy.

65

65

Fuld

AUGUST 26, 2022

Phronesis Partners and Fuld & Company today announced the appointment of Elaine Pratt to the role of Group Chief Marketing Officer. In this capacity, Elaine will lead the marketing strategy and activities for the two brands. By: Phronesis Partners and Fuld & Company. BOSTON – Aug 25, 2022 – Phronesis Partners and Fuld & Company, a fast-growing research, analytics, and advisory business, today announced the appointment of Elaine Pratt to the role of Group Chief Marketing Officer.

Communication 52

Communication 52

Pharmaceutical Technology

AUGUST 26, 2022

Amid a shortage of monkeypox vaccine doses, the WHO and FDA have declared public health emergencies, and the FDA has granted its first Emergency Use Authorization (EUA) to a monkeypox vaccine and opened the door for more. On August 4, the US Department of Health and Human Services (HHS) declared monkeypox a public health emergency, a move required to grant EUAs.

Vaccines 52

Vaccines FDA Immunization 52